Zymeworks BC Inc’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $17.70 on 11/12/24 and a low of $7.97 for the same time frame on 04/26/24.
52-week price history of ZYME Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Zymeworks BC Inc’s current trading price is -34.86% away from its 52-week high, while its distance from the 52-week low is 44.67%. The stock’s price range during this period has spanned from $7.97 to $17.70. In the Healthcare sector, the Zymeworks BC Inc’s shares surpassed a trading volume of approximately 0.37 million for the day, which was noticeably lower compared to the average daily volume of 9.0.62 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Zymeworks BC Inc (ZYME) has experienced a quarterly decline of -17.58% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 808.80M and boasts a workforce of 286 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 13.34, with a change in price of -3.02. Similarly, Zymeworks BC Inc recorded 578,559 in trading volume during the last 100 days, posting a change of -20.76%.
Examining ZYME’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for ZYME stands at 0.05. Similarly, the long-term debt-to-equity ratio is also 0.05.
ZYME Stock Stochastic Average
Today’s raw stochastic average for Zymeworks BC Inc over the last 50 days is 40.19%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 58.89%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 52.06% and 47.66%, respectively.
ZYME Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. Year to date metric has recorded a loss of -21.24%.However, over the last six months, we can see a stronger performance of -17.20%. Over the last 30 days, the price of ZYME has leaped by -9.85%. And in the last five days, it has surged by 22.14%.
